Medifast (NYSE:MED) Issues Quarterly Earnings Results

Medifast (NYSE:MED) issued its earnings results on Monday. The specialty retailer reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.20), Zacks reports. Medifast had a return on equity of 2.00% and a net margin of 0.76%. Medifast updated its Q4 2025 guidance to -1.250–0.70 EPS.

Medifast Stock Down 1.6%

Shares of MED stock traded down $0.19 during mid-day trading on Monday, reaching $11.83. The company’s stock had a trading volume of 175,051 shares, compared to its average volume of 209,198. Medifast has a 12-month low of $11.57 and a 12-month high of $21.98. The firm has a market capitalization of $130.02 million, a PE ratio of 36.97 and a beta of 0.85. The company’s 50 day simple moving average is $13.57 and its 200-day simple moving average is $13.54.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Medifast in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average target price of $16.50.

Institutional Investors Weigh In On Medifast

Hedge funds and other institutional investors have recently modified their holdings of the stock. Bank of America Corp DE boosted its holdings in shares of Medifast by 37.4% in the 2nd quarter. Bank of America Corp DE now owns 396,369 shares of the specialty retailer’s stock valued at $5,569,000 after buying an additional 107,854 shares during the period. Man Group plc boosted its holdings in shares of Medifast by 0.6% in the 2nd quarter. Man Group plc now owns 198,156 shares of the specialty retailer’s stock valued at $2,784,000 after buying an additional 1,200 shares during the period. AQR Capital Management LLC boosted its holdings in shares of Medifast by 14.5% in the 1st quarter. AQR Capital Management LLC now owns 199,750 shares of the specialty retailer’s stock valued at $2,693,000 after buying an additional 25,366 shares during the period. Ameriprise Financial Inc. boosted its holdings in shares of Medifast by 9.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 76,801 shares of the specialty retailer’s stock valued at $1,079,000 after buying an additional 6,322 shares during the period. Finally, Bridgeway Capital Management LLC boosted its holdings in shares of Medifast by 164.6% in the 2nd quarter. Bridgeway Capital Management LLC now owns 57,944 shares of the specialty retailer’s stock valued at $814,000 after buying an additional 36,044 shares during the period. Institutional investors own 95.51% of the company’s stock.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.